to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Jeff Hawkins is the Founder of Numenta, but he is also well known as the co-founder of two companies, Palm and Handspring, and as the architect of many computing products, such as the PalmPilot and the Treo smartphone.
Throughout his life Hawkins has also had a deep interest in neuroscience and theories of the neocortex. His interest in the brain led him to create the non-profit Redwood Neuroscience Institute (RNI), a scientific organization focused on
understanding how the human neocortex processes information. While at RNI, Hawkins developed a theory of neocortex which appeared in his 2004 book, On Intelligence. Along with Dileep George and Donna Dubinsky, Hawkins
founded Numenta in 2005 to develop a technology platform derived from his theory. It is his hope that Numenta will play a catalytic role in creating an industry based on this theory and technology. Jeff Hawkins earned his B.S. in
electrical engineering from Cornell University in 1979. He was elected to the National Academy of Engineering in 2003.
Numenta's Jeff Hawkins, a frequent company founder, inventor, and product designer for Palm and Handspring, highlights lessons learned during his tenure in technology. He also confesses that these accomplishments were mere way stations in his 30-year passionate pursuit of neuroscience.
Making a poor choice in selecting business software for your company can lead to inefficiencies and costly errors. This article offers key points entrepreneurs should consider to make the right software selection at the start.
Danish-born David Heinemeier Hansson is the programmer and creator of the popular Ruby on Rails web development framework and the Instiki wiki. He is also a partner at the Web-based software development firm 37signals,
based in Chicago. Ruby on Rails provides a "basic development environment" for programmers, according to Wikipedia.org. Based on the programming language Ruby (developed by Japanese programmer Yukihiro Matsumoto in 1995), Ruby on Rails
focuses on user interface and "convention over configuration"; meaning, developers can focus on the unique qualities of their Web site or program rather than the building blocks that every application may require. Released in 2004, Ruby on
Rails has been incorporated into many applications used by some of the biggest companies, from Twitter to Apple's 2007 release of Mac OS X v.10.5 "Leopard." Aside from his development of Ruby on Rails, Heinemeier Hansson also works as a
partner for Web-based software development firm 37signals. Joining the company in 2003, he has helped develop Basecamp, Campfire, Backpack and other Web-based applications. Working in similar ways like Web-based e-mail services like Yahoo!
e-mail and Google's Gmail, 37signals hosts a broad range of IT services for companies, including project management to information-sharing. The firm's software has been used by Kellogg's, Sun Microsystems and even Obama '08. Hansson
received his bachelor's degree from the Copenhagen Business School in 2005. In that same year, he moved to Chicago and received Hacker of the Year honors for his work on Ruby on Rails from Google and O'Reilly Media. He runs a blog called
Databases are an essential tool for matching buyers and sellers for specialty products and services, says the founder of the nation's largest database company servicing small businesses.
A treatment for tinnitus is the goal of two Ohio University colleagues who were frustrated by the lack of options for those suffering from this hearing disorder. Read more to find out how this medical device differs from its competitors.
Biotech companies will have a new resource in the Ohio University Innovation Center’s new biotech research and development facility. Read more to learn about what it will offer.
Every year Cleveland Clinic compiles a list of the best healthcare innovations for the future. Here are our suggestions for the best healthcare innovations in recent biotech news.
Mr. Gifford leads The Foundry in all of its activities, including the identification and early development of new technologies, the formation, staffing and growth of new companies, and serving as a board member of the
new ventures. Most recently, Mr. Gifford was Vice President of Research and Development at Heartport, Inc.. From 1993-1998, he built and led a 62-person team developing a wide variety of novel devices and procedures for Minimally Invasive
Cardiac Surgery that were instrumental in the company's enormously successful public offering in 1996. Heartport's market capitalization at its peak in 1996 reached over $1 billion. In 1992, Mr. Gifford and Professor Dr. Berthold Hoefling
co-founded Bavaria Medizin Technologie (BMT), GmbH, to develop innovative drug delivery catheters and to establish a German source for innovation and production of catheters for Interventional Cardiology. During the two-year period
following the founding of this business, he served in the role of Managing Director of BMT until such time as he transitioned management of the company to a German national. In 1990, Mr. Gifford and John B. Simpson, MD, Ph.D., founded
Cardiovascular Therapeutic Technologies, Inc., a business devoted to the development of innovative local drug delivery catheters for thrombolytic and antiproliferative agents. Eli Lilly and Company acquired this business for its technology
in 1991, and it became the original basis for Guidant's Compass organization. From 1985-1990, Mr. Gifford worked at Devices for Vascular Intervention (DVI), where he was the driving force behind the design of the company's first generation
Peripheral and Coronary atherectomy systems. In addition, during this period he served in various Clinical Research and Marketing capacities. Before joining DVI, Hanson worked in an engineering role at Oximetrix, Inc., working in the field
of intravascular blood gas monitoring
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.